Publications by authors named "J Llorente"
The second Latin American catheter ablation registry ("II LAHRS EP registry").
J Interv Card Electrophysiol
November 2024
Background: Patient's clinical characteristics, technical resources, center and operator volume, and operator experience and training are known variables impacting outcomes. Although international standards have been agreed to maximize the benefits of this therapy, regional and global differences still exist. Latin American information has not been updated in the last 10 years.
View Article and Find Full Text PDFArticle Synopsis
- * A 55-year-old male patient was diagnosed with HMSC, confirmed through various techniques, including immunohistochemistry (IHC) and genetic testing (PCR and RNA ISH), leading to successful treatment via surgery and radiotherapy.
- * Whole exome sequencing (WES) identified 38 gene mutations and provided insights into possible personalized therapy targets, while no mutations were found to suggest drug response according to established databases.
Objectives: Dynamic trends of invasive pneumococcal disease (IPD) including the evolution of prevalent serotypes are very useful to evaluate the impact of current and future pneumococcal conjugate vaccines (PCVs) and the rise of non-vaccine serotypes. In this study, we include epidemiological patterns of S. pneumoniae before and after COVID-19 pandemic.
View Article and Find Full Text PDFDesign, In Vitro Evaluation and In Vivo Biocompatibility of Additive Manufacturing Three-Dimensional Printing of β beta-Tricalcium Phosphate Scaffolds for Bone Regeneration.
Biomedicines
May 2024
The reconstruction of bone deficiencies remains a challenge due to the limitations of autologous bone grafting. The objective of this study is to evaluate the bone regeneration efficacy of additive manufacturing of tricalcium phosphate (TCP) implants using lithography-based ceramic manufacturing (LCM). LCM uses LithaBone TCP 300 slurry for 3D printing, producing cylindrical scaffolds.
View Article and Find Full Text PDFBackground: Recurrent intestinal-type sinonasal adenocarcinoma (ITAC) can occur several years after primary treatment and with different histology. We aimed to clarify if such recurrences could be second primary tumors and to identify actionable mutations as targets for personalized treatment of recurrent ITAC.
Methods: Twelve pairs of primary and recurrent ITAC were histologically examined and analyzed by next-generation sequencing.